ANI PHARMACEUTICALS, INC (ANIP) Total liabilities 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) total liabilities at each fiscal year-end, per SEC filings.
$899.7MFY2025 · since FY2016: $153.2M → $899.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $899.7M | +5.1% |
| FY2024 | $855.9M | +91.6% |
| FY2023 | $446.8M | +6.0% |
| FY2022 | $421.5M | +2.1% |
| FY2021 | $412.9M | +55.5% |
| FY2020 | $265.5M | +8.8% |
| FY2019 | $244.0M | +4.6% |
| FY2018 | $233.3M | -1.7% |
| FY2017 | $237.4M | +54.9% |
| FY2016 | $153.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice